AlzeCure presents new anti-inflammatory data with NeuroRestore ACD856 at the Alzheimer’s conference CTAD
October 17, 2024
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer&#...